Isolation, Primary Structure, and Synthesis of Human Hypothalamic Somatocrinin: Growth Hormone-releasing Factor

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1984 Jul 1

PMID 6431406

Citations 31

Authors

N Ling

F Esch

P Bohlen

P BRAZEAU

W B Wehrenberg

R Guillemin

Affiliations

Soon will be listed here.

Abstract

The hypophysiotropic peptide, growth hormone-releasing factor (GRF), was isolated from human hypothalamic-hypophysial tissues by means of acid extraction, immunoaffinity chromatography, gel filtration, and two steps of reverse-phase high-performance liquid chromatography. Amino acid sequence determination using a gas-phase sequencer and reverse-phase liquid chromatography of the native peptide and its synthetic replicates showed its primary structure to be as follows: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln -Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser -Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2, which is identical to that of the GRF recently isolated and characterized from a human pancreatic tumor that had caused acromegaly. Human hypothalamic GRF shows major homologies (93%, 89%, and 86%, respectively) when its primary structure is compared to that of the hypothalamic GRF from the porcine, bovine, caprine, and ovine species.

Citing Articles

Growth hormone-releasing hormone signaling and manifestations within the cardiovascular system.

Dulce R, Hatzistergos K, Kanashiro-Takeuchi R, Takeuchi L, Balkan W, Hare J Rev Endocr Metab Disord. 2025; .

PMID: 39883351 DOI: 10.1007/s11154-024-09939-0.

Update on regulation of GHRH and its actions on GH secretion in health and disease.

Montero-Hidalgo A, Del Rio-Moreno M, Perez-Gomez J, Luque R, Kineman R Rev Endocr Metab Disord. 2025; .

PMID: 39838154 DOI: 10.1007/s11154-025-09943-y.

The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.

Schally A, Cai R, Zhang X, Sha W, Wangpaichitr M Rev Endocr Metab Disord. 2024; .

PMID: 39592529 DOI: 10.1007/s11154-024-09929-2.

Growth hormone-releasing hormone and its analogues in health and disease.

Granata R, Leone S, Zhang X, Gesmundo I, Steenblock C, Cai R Nat Rev Endocrinol. 2024; 21(3):180-195.

PMID: 39537825 DOI: 10.1038/s41574-024-01052-1.

GHRH and the prostate.

Munoz-Moreno L, Roman I, Bajo A Rev Endocr Metab Disord. 2024; .

PMID: 39505776 DOI: 10.1007/s11154-024-09922-9.

References

Monahan M, Gilon C . A rapid method for the preparation of amino acid resin esters for Merrifield solid-phase peptide synthesis. Biopolymers. 1973; 12(11):2513-9. DOI: 10.1002/bip.1973.360121106. View

Esch F, Bohlen P, Ling N, BRAZEAU P, Guillemin R . Isolation and characterization of the bovine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun. 1983; 117(3):772-9. DOI: 10.1016/0006-291x(83)91664-9. View

Imura H . Ectopic hormone production viewed as an abnormality in regulation of gene expression. Adv Cancer Res. 1980; 33:39-75. DOI: 10.1016/s0065-230x(08)60668-5. View

Benoit R, Bohlen P, Ling N, Briskin A, Esch F, BRAZEAU P . Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci U S A. 1982; 79(3):917-21. PMC: 345864. DOI: 10.1073/pnas.79.3.917. View

Guillemin R, BRAZEAU P, Bohlen P, Esch F, Ling N, Wehrenberg W . Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982; 218(4572):585-7. DOI: 10.1126/science.6812220. View

Rivier J, Spiess J, Thorner M, Vale W . Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature. 1982; 300(5889):276-8. DOI: 10.1038/300276a0. View

Bohlen P, Schroeder R . High-sensitivity amino acid analysis: methodology for the determination of amino acid compositions with less than 100 picomoles of peptides. Anal Biochem. 1982; 126(1):144-52. DOI: 10.1016/0003-2697(82)90120-8. View

Esch F, Bohlen P, Ling N, Brazeau P, Wehrenberg W, Guillemin R . Primary structures of three human pancreas peptides with growth hormone-releasing activity. J Biol Chem. 1983; 258(3):1806-12. View

Esch F, Bohlen P, Ling N, Brazeau P, Wehrenberg W, Thorner M . Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochem Biophys Res Commun. 1982; 109(1):152-8. DOI: 10.1016/0006-291x(82)91578-9. View

10.

Spiess J, Rivier J, Vale W . Characterization of rat hypothalamic growth hormone-releasing factor. Nature. 1983; 303(5917):532-5. DOI: 10.1038/303532a0. View

11.

Gubler U, Monahan J, Lomedico P, Bhatt R, Collier K, HOFFMAN B . Cloning and sequence analysis of cDNA for the precursor of human growth hormone-releasing factor, somatocrinin. Proc Natl Acad Sci U S A. 1983; 80(14):4311-4. PMC: 384027. DOI: 10.1073/pnas.80.14.4311. View

12.

Bohlen P, BRAZEAU P, Bloch B, Ling N, Gaillard R, Guillemin R . Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochem Biophys Res Commun. 1983; 114(3):930-6. DOI: 10.1016/0006-291x(83)90649-6. View

13.

Mayo K, Vale W, Rivier J, Rosenfeld M, Evans R . Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature. 1983; 306(5938):86-8. DOI: 10.1038/306086a0. View

14.

Bohlen P, Esch F, BRAZEAU P, Ling N, Guillemin R . Isolation and characterization of the porcine hypothalamic growth hormone releasing factor. Biochem Biophys Res Commun. 1983; 116(2):726-34. DOI: 10.1016/0006-291x(83)90585-5. View

15.

NOBLE R, Yamashiro D, Li C . Synthesis of a nonadecapeptide corresponding to residues 37-55 of ovine prolactin. 1 Detection and isolation of the sulfonium form of methionine-containing peptides. J Am Chem Soc. 1976; 98(8):2324-8. DOI: 10.1021/ja00424a055. View